Pesquisa

Pesquisa em todas as categorias
Filtros suplementares
Palavras chave	Remover

Pesquisa nas categorias
Autores
Título
Resumo
Texto integral
Pesquisar em PDF
Arquivos suplementares
Data da publicação
de
a
Termos
Áreas de conhecimento
Método
Onde e quando
Todos os campos dos termos indexados

Edição

Título

Autores

Nº 5 (2023)

Efficiency and safety of the drug adenoprosin in patients with prostate diseases. A systematic review and meta-analysis

Morozov А., Timofeeva Е., Suvorov А., Allenov S., Spivak L.

(Rus)

Nº 6 (2023)

Evaluation of the effect of Alfuprost® MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia

Kuzmenko A., Kuzmenko V., Gyaurgiev T.

(Rus)

Nº 2 (2023)

The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)

Kogan M., Avadieva N., Gevorkyan L., Loginov Y., Metelkin A., Mitin A., Patrikeev A.

(Rus)

Nº 4 (2023)

The comparative analysis of surgical procedures a in patients with benign prostatic hyperplasia and type 2 diabetes mellitus

Volkov S., Mikheev R., Grigoryan O., Andreeva E.

(Rus)

Nº 1 (2020)

Lower urinary tract symptoms after transurethral resection of the prostate

Ergakov D., Martov A., Turin D., Andronov A.

(Rus)

Nº 3 (2018)

Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy

Popov S., Guseinov R., Skryabin O., Orlov I., Martov A.

(Rus)

Nº 6 (2022)

The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia

Pavlov V., Kazikhinurov A., Kazikhinurov R., Sabirzyanov S., Saleeva Y., Kazikhinurova K.

(Rus)

Nº 1 (2022)

The role of angiotensinconverting enzyme and angiotensin II receptors of the second type in the pathogenesis of proliferative diseases of the prostate

Chibichyan M., Chernogubova E., Avetyan A., Lapteva T., Pavlenko I., Kogan M.

(Rus)

Nº 1 (2017)

X-RAY-GUIDED ENDOVASCULAR SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER

Neimark A., Tachalov M., Neimark B., Torbik D., Arzamastsev D.

(Rus)

Nº 4 (2019)

VITAPROST FORTE IN THE TREAMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: PATHOGENETIC BASICS AND CLINICAL RESULTS

Kuz’min I.

(Rus)

Nº 3 (2021)

Multicenter randomized study of bovhyalu-ronidase azoximer (Longidaza®) in men after transuretral resection of the prostate

Kotov S., Bolotov A., Belomyttsev S., Surenkov D., Vorobyova A.

(Rus)

Nº 6 (2017)

CURRENT APPROACHES TO CONSERVATIVE TREATMENT OF MEN WITH CONCOMITANT BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION

Kamalov A., Takhirzade A.

(Rus)

Nº 2 (2019)

Efficiency and safety of silodosin for treatment of lower urinary tract symptoms, associated of benign prostatic hyperplasia

Krivoborodov G., Tur E.

(Rus)

Nº 2 (2022)

Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice

Kuzmenko A., Gyaurgiev T., Kuzmenko G.

(Rus)

Nº 3 (2020)

Combination of a1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study

Borisov V.

(Rus)

Nº 3 (2019)

Super-selective prostatic artery embolization for bph treatment

Karpov V., Kapranov S., Shaparov B., Osmolovskiy B., Kamalov D., Kamalov A.

(Rus)

Nº 4 (2018)

Patients with newly diagnosed benign prostatic hyperplasia

Meshkov I., Kulchavenya E., Shevchenko S., Neimark A.

(Rus)

Nº 3 (2017)

Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies

Korneev I.

(Rus)

Nº 1 (2015)

RISK FACTORS FOR ANTERIOR URETHRAL STRICTURES AFTER TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA

Grechenkov A., Glybochko P., Alyaev Y., Bezrukov E., Vinarov A., Butnaru D., Sukhanov R.

(Rus)

Nº 3 (2022)

THE ROLE OF SYSTEMATIZATION OF POSTOPERATIVE COMPLICATIONS IN ASSESSING THE EFFICIENCY AND SAFETY OF SURGICAL METHODS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Giyasov S., Gafarov R., Shodmonova Z., Mukhtarov S., Akilov F.

(Rus)

Nº 2 (2017)

INTRAVESICAL PROSTATIC PROTRUSION IN DIAGNOSING INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

Krivoborodov G., Efremov N., Bolotov A.

(Rus)

Nº 5 (2017)

THE USE OF PROSTADOZ IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND COEXISTENT HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA

Antonov A., Gordeev V., Fedorchuk S., Laptev D.

(Rus)

Nº 2 (2022)

Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice

Novikov A., Shpilenya E.

(Rus)

Nº 4 (2016)

Features of diagnosis and treatment of various disorders of urination by physicians of the Republic of Dagestan and other regions of the North Caucasus and Southern Federal districts

Gadzhieva Z., Kazilov Y., Alyaev Y., Aboyan I.

(Rus)

Nº 1 (2018)

COMBINATION DRUG THERAPY IN PATIENTS WITH BPH

Kuz’menko A., Kuz’menko V., Gyaurgiev T.

(Rus)

Nº 1 (2018)

QUALITY OF LIFE IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AFTER TURP FOR BENIGN PROSTATIC HYPERPLASIA

Pushkar D., Bernikov A., Khodyreva L., Dudareva A., Al'-Shukri S., Amdii R., Aboyan I., Shiranov K., Medvedev V., Efremov M.

(Rus)

Nº 3 (2019)

A comparison between enucleation of the prostate using holmium and thulium laser in volume over 80 cc: retrospective clinical study with 12-months follow-up

Popov S., Orlov I., Martov A., Malevich S., Sushina I., Grin E., Obidnyak V., Dovganskiy D., Topuzov T.

(Rus)

Nº 5 (2015)

FEATURES OF CLINICAL COURSE AND MORPHOMETRIC PARAMETERS OF BENIGN PROSTATIC HYPERPLASIA IN MEN WITH METABOLIC SYNDROME AND ANDROGEN DEFICIENCY

Tyuzikov I., Grekov E., Kalinchenko S.

(Rus)

Nº 5 (2014)

TRANSURETHRAL ELECTROENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA

Martov A., Ergakov D., Andronov A., Baykov N.

(Rus)

Nº 6 (2022)

Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis

Kuzmenko A., Kuzmenko V., Gyaurgiev T., Kuzmenko G.

(Rus)

Nº 2 (2017)

RATIONALE OF PHARMACOTHERAPY DURATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (A CLINICAL-MORPHOLOGICAL STUDY)

Sitdykova M., Tsyplakov D., Sitdykov E., Nurtdinov A.

(Rus)

Nº 6 (2017)

TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND ASSESSMENT OF INTRAVESICAL PROSTATIC PROTRUSION

Krivoborodov G., Efremov N., Bolotov A.

(Rus)

Nº 6 (2021)

An observational randomized study of the efficacy and safety of the drug Longidase®, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia

Kuzmenko A., Kuzmenko V., Gyaurgiev T., Vinnik Y.

(Rus)

Nº 6 (2019)

Economic aspects of treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia

Startsev V., Dudarev V., Sevryukov F., Zabrodina N.

(Rus)

Nº 3 (2019)

The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-naive patients with benign prostatic hyperplasia

Kupriyanov Y., Rasner P., Rokhlikov I., Akrikidi A., Soloviev V., Markov A., Nozdrin E., Logvinov L., Vasilevskiy R., Skrupskiy K., Pushkar D., Putilovskiy M., Epstein O.

(Rus)

Nº 3 (2018)

Approaches to medical management of patients with high risk of progressing of benign prostatic hyperplasia depending on concomitant erectile dysfunction

Kamalov A., Takhirzade A.

(Rus)

Nº 1 (2017)

PREVENTION OF THROMBOHEMORRHAGIC POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Atamanova E., Andryukhin M., Vasilenko I., Makarov O.

(Rus)

Nº 5 (2015)

SILODOSIN IN THE TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA - RESULTS OF RUSSIAN MULTICENTER OBSERVATIONAL STUDY

Pushkar D., Bernikov A., Sadchenko A.

(Rus)

Nº 4 (2014)

Ejaculatory-protective transurethral resection of the prostate

Martov A., Andronov A., Dutov S., Baykov N.

(Rus)

Nº 6 (2022)

Efficacy and safety of intermittent catheterization for acute urinary retention: a prospective comparative randomized study

Malkhasyan V., Kotov S., Mamaev I., Belomytcev S., Perov R., Pulbere S., Volnukhin A., Pushkar D.

(Rus)

Nº 2 (2017)

ANALYSIS OF FACTORS AFFECTING THE COMPLIANCE WITH MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA

Malkhasyan V., Rasner P., Gevorkyan A., Semenyakin I., Tedeev A., Pushkar D.

(Rus)

Nº 2 (2019)

A case of successful plasma transurethral enucleationof benign prostatic hyperplasia the size of 530 cm3

Sevryukov F., Nakagawa K., Kochkin A., Volodin M., Semenychev D.

(Rus)

Nº 5 (2021)

Predictors of bladder neck contracture after transurethral procedure on the prostate

Abbosov S., Sorokin N., Kadrev A., Shomarufov A., Nesterova O., Akilov F., Kamalov A.

(Rus)

Nº 5 (2019)

Efficacy of 5a-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia

Nizov A.

(Rus)

Nº 3 (2019)

Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts

Sivkov A., Golovanov S., Zhukova L.

(Rus)

Nº 4 (2015)

Treatment of erectile dysfunction following transvesical prostatectomy

Motin P., Andrjuhin M., Pulbere S., Alekseev O., Agaev N.

(Rus)

Nº 4 (2012)

MODIFIED METHOD OF RETROPUBIC PROSTATECTOMY (RMAPE METHOD)

Veliyev E., Sokolov A., Bogdanov A., Ilyushin L.

(Rus)

Nº 6 (2017)

COMPARATIVE ASSESSMENT OF TREATMENTS FOR PROSTATE ADENOMA GREATER THAN 100 CM3

Orlov I., Popov S., Martov A., Gallyamov E., Malevich S., Sushina I., Grin’ E., Sanzharov A., Novikov A., Sergeev V., Kochkin A.

(Rus)

Nº 5 (2021)

Experimental study on the efficiency of rectal suppositories with oxidized dextran in patients with benign prostatic hyperplasia

Novikova E., Troitsky A., Ukah H., Selyatitskaya V.

(Rus)

Nº 3 (2019)

Treatment of patients with lower urinary tract symptoms in Moscow

Pushkar D., Rasner P., Kotenko D., Gerasimov A., Shabalkin S.

(Rus)

Nº 2 (2018)

Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms

Amdii R., Al’-Shukri A.

(Rus)

Nº 2 (2015)

Superselective prostatic artery embolization as a preparatory step before turp in the treatment of benign prostatic hyperplasia in patients with large prostates

Nejmark A., Nejmark B., Tachalov M., Arzamascev D., Torbik D.

(Rus)

Nº 2 (2012)

PRIMENENIE PROSTAGUT FORTE U BOL'NYKh ADENOMOY PREDSTATEL'NOY ZhELEZY S SOPUTSTVUYuShchIM KhRONIChESKIM PROSTATITOM

Avdoshin V., Pulbere S.

(Rus)

Nº 5 (2017)

ULTRASOUND INDICATORS OF THE PROSTATE, URINARY BLADDER AND UROFLOWMETRY PARAMETERS IN THE DIAGNOSIS OF INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

Krivoborodov G., Efremov N., Bolotov A.

(Rus)

Nº 3 (2021)

The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis

Kuzmenko A., Vinnik Y., Kuzmenko V., Gyaurgiev T.

(Rus)

Nº 4 (2019)

EFFICIENCY OF PHOSPHODIESTERASE-5 INHIBITORS FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT ERECTILE DYSFUNCTION

Kamalov A., Nizov A.

(Rus)

Nº 1 (2019)

The efficacy of fesoterodine in patients after transurethral resection of the prostate

Kuz’menko A., Kuz’menko V., Gyaurgiev T.

(Rus)

Nº 2 (2018)

The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)

Loran O., Seregin A.

(Rus)

Nº 5 (2016)

Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia

Glybochko P., Alyaev Y., Pshikhachev A., Sorokin N., Dymov A.

(Rus)

Nº s3 (2017)

Conservative management of benign prostatic hyperplasia: are urologists satisfied?

Govorov A.

(Rus)

Nº 4 (2019)

A COMPARATIVE CHARACTERISTICS OF TREATMENT RESULTS OF PATIENS WITH BENIGN PROSTATIC HYPERPLASIA IN COMBINATION WITH HYPOGONADISM

Kamalov A., Vasilevskiy R., Okhobotov D., Neplokhov E.

(Rus)

Nº 2 (2018)

The effects of combination therapy with 5a-reductase inhibitor and a-blocker on the prognosis of BPH

Neimark A., Davydov A., Aliev R.

(Rus)

Nº 4 (2016)

Monopolar transurethral enucleation of benign prostatic hyperplasia. Our initial experience

Tsarichenko D., Simberdeev R., Glybochko P., Alyaev Y., Rapoport L., Sukhanov R., Sorokin N., Enikeev D., Davydov D.

(Rus)

Nº 1 (2015)

TREATMENT OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Kaprin A., Kostin A., Vinogradov I., Magamadov E.

(Rus)

Nº 3 (2022)

POSTCOVID COMPLICATIONS IN UROLOGY. PREVENTION

Kuzmenko A., Kuzmenko V., Gyaurgiev T.

(Rus)

1 - 65 de 65 resultados

Dicas:

Palavras-chave são sensíveis a maiúsculas
Preposições e conjunções ingleses são ignoradas
Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
Use OR para pesquisar um termo exato, ex.: educação OR formação
Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Nome de usuário
Senha
Lembrar usuário

Esqueceu a senha?	Cadastro

Nome de usuário
Senha
Lembrar usuário

Esqueceu a senha?	Cadastro

Pesquisa

Filtros suplementares

Pesquisa nas categorias

Data da publicação

Termos

Este site utiliza cookies